Cellartis receives 3 365 000 SEK for stem cell research
VINNOVA, the Swedish agency of Innovation, grant Cellartis 3 365 000 SEK to enable toxicity studies on human embryonic stem cells.
The “Forska&Väx" program at VINNOVA continues to receive funds from the government and can hence continue to support small research companies in their R&D investments. This year 52 million SEK has all together been granted research activities within small companies.In this forth round of financing 18 companies has been granted funds for R&D activities. The next call will close the 2nd of April 2007 and decisions will be announced in the middle of may 2007. Three types of activities can be granted funds; pilot studies, demand studies and pure R&D activities - read more at VINNOVA.
